Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,011 | -7,934 | -23,321 | -17,002 | -11,151 |
| Depreciation Amortization | 425 | 212 | 788 | 573 | 372 |
| Accounts payable and accrued liabilities | 104 | -106 | -909 | -962 | -1,095 |
| Other Working Capital | 1,082 | 133 | -1,171 | 65 | -1,595 |
| Other Operating Activity | 1,923 | 1,072 | 4,142 | 3,516 | 3,020 |
| Operating Cash Flow | $-11,477 | $-6,623 | $-20,471 | $-13,810 | $-10,449 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -274 | -62 | -1,273 | -1,087 | -1,064 |
| Other Investing Activity | 1,245 | 747 | 996 | -249 | 1,743 |
| Investing Cash Flow | $971 | $685 | $-277 | $-1,336 | $679 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 456 | 456 | N/A |
| Debt Repayment | -47 | -32 | -122 | -90 | -51 |
| Common Stock Issued | 49,416 | 49,035 | 1,285 | 922 | 709 |
| Common Stock Repurchased | N/A | N/A | -4 | -4 | -4 |
| Other Financing Activity | -74 | -37 | -107 | -71 | -47 |
| Financing Cash Flow | $49,295 | $48,966 | $1,508 | $1,213 | $607 |
| Beginning Cash Position | 20,250 | 20,250 | 39,490 | 39,490 | 39,490 |
| End Cash Position | 59,039 | 63,278 | 20,250 | 25,557 | 30,327 |
| Net Cash Flow | $38,789 | $43,028 | $-19,240 | $-13,933 | $-9,163 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,477 | -6,623 | -20,471 | -13,810 | -10,449 |
| Capital Expenditure | -274 | -62 | -1,323 | -1,137 | -1,114 |
| Free Cash Flow | -11,751 | -6,685 | -21,794 | -14,947 | -11,563 |